Fig. 4From: Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapyKaplan Meier plots of Ki-67, subtype and pathological response in pPR group. Ki-67 at 20% threshold and pPR subgroups failed, while Ki-67 at 30% cut-off point and subtype were suitable to separate good and unfavorable patient cohorts regarding OSBack to article page